Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

LifeStance Health Partners with DocASAP to Enhance Patient Experience and Streamline Access to Care


News Image

“We’re humbled to help LifeStance ensure patients seeking behavioral health services get the timely care they need, particularly during these challenging times,” said Puneet Maheshwari, co-founder and CEO of DocASAP.

DocASAP, the industry’s most advanced patient access and engagement platform for health systems, health plans and physician groups, today announced LifeStance Health, a leader in behavioral healthcare services, selected its platform to streamline patient and member access to care. Through advanced online scheduling options, including accessing telehealth visits, the strategic partnership empowers LifeStance to navigate patients across 15 states to the right provider and setting at the right time.

“Timely access to care – especially during stressful times – is critical to ensuring positive, lasting outcomes for our patients,” said Danish Qureshi, chief growth officer, LifeStance. “DocASAP’s robust technology allows us to quickly scale and create a better online scheduling experience for patients and our 2,000 providers. By lowering barriers to accessing care, both in-person and through telehealth, we’re able to efficiently navigate patients to the care they need, where and when they need it.”

The COVID-19 crisis is projected to push telehealth visits over one billion in 2020, according to Forrester Research. DocASAP’s secure platform will empower LifeStance to further streamline access to telehealth and in-person visits. The platform’s provider search and profiles and real-time accurate online appointment scheduling will help facilitate patient acquisition through LifeStance’s regional and national websites, as well as digital health plan channels. Additionally, DocASAP’s frictionless platform will accommodate LifeStance’s multiple visit reasons, complex workflows, provider questions and integrate with their practice management solution.

“COVID-19 is dramatically transforming how we access and deliver care,” said Puneet Maheshwari, co-founder and CEO of DocASAP. “As we adjust to a new normal, navigating patients to the right provider and setting at the right time remains our top priority. We’re humbled to help LifeStance ensure patients seeking behavioral health services get the timely care they need, particularly during these challenging times.”

About LifeStance Health

LifeStance is a national provider of behavioral healthcare services with operations across the country. Founded in 2017, LifeStance brings together psychiatrists, psychologists, nurse practitioners, and licensed therapists to provide comprehensive mental health treatment services for patients of all ages. Every LifeStance team member is dedicated to providing the utmost in compassionate care and treatment to serve the specific needs and concerns of each individual patient. To learn more, please visit http://www.LifeStance.com.

About DocASAP

DocASAP provides the industry’s most advanced patient access and engagement platform for health systems, health plans and physician groups. DocASAP empowers organizations to direct patients to the optimal provider and care setting at the right time throughout their access journey, helping improve outcomes, reduce costs and create a better patient experience. Backed and promoted in the market by Aetna, Optum and UnitedHealthcare, DocASAP builds unique payor-provider connections with an eye toward simplified access, increased care compliance and improved population risk management. For more information, visit http://docasap.com or follow on Twitter @DocASAP.

Share article on social media or email:



Genedata Partners with Cergentis to Provide End-to-end Solution for Automating TLA-based Clone Selection


News Image

TLA, together with Genedata Selector, enables our customers to scale up their cell line development processes and generate results of the highest quality

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the availability of Genedata Selector® for automating the Targeted Locus Amplification (TLA) data analysis workflow. The software solution is the result of a close collaboration with Cergentis, an innovative leader in the genomics space and the developer and provider of the TLA technology, together with joint customers in the biopharmaceutical industry.

The cutting-edge TLA technology is used during cell line development to standardize and speed up the clone selection process. With TLA, Cergentis provides a cost-efficient, high resolution technology to determine transgene integration sites and detect single nucleotide and structural variants in the transgene sequence, as well as structural changes in and surrounding transgene sequences. This information is highly relevant to quickly assess the quality of cell line clones during cell line development. TLA also detects sequence changes resulting from targeted genome editing (such as CRISPR) and/or targeted transgene integrations.

As the technology is now being implemented in many biopharmaceutical R&D organizations to speed and scale up the experimental throughput, the need has emerged for a scalable computational solution that allows customers to rapidly analyze their own TLA data to accelerate decision making during the cell line development process. Besides scalability, key requirements for such a computational solution are workflow integration from sample registration to reporting, plus ease of use from the perspective of a scientist.

Genedata Selector is the first-in-class software platform that satisfies these key requirements. Providing an end-to-end solution, it offers sample registration capabilities and includes the option of full automation of the highly complex sequence data analysis process. Intuitive visualizations enable quick decision making and can be easily integrated into reports used for regulatory purposes.

Highly cost- and time-efficient, Genedata Selector:

  • offers full automation of the data analysis workflow, speeds up complex analysis workflows, enables high experimental throughput, and delivers data analysis results without the need for special data analysis expertise;
  • maintains a full track record of analyzed clones, including clone hierarchies, with audit trail functionality that allows deployment in a regulatory-compliant environment;
  • reduces by orders of magnitude the analysis time from project initiation to reporting of results;
  • can be deployed on premises as well as under a Managed SaaS model.

“Genedata developed a push button system including a fully integrated analysis pipeline, to allow our customers in cell line development to get a comprehensive analysis report, including visual representation of integration sites,” said Max van Min, Founding Director of Cergentis. “Our customers now have available a computational platform that supports our market-leading TLA technology and enables them to significantly increase the number of clones analyzed, thereby increasing the efficiency of their quality control and cell line development workflow.”

“We are very pleased with our collaboration with Cergentis, a highly innovative company providing services and kits to improve the efficiency of cell line development. With Genedata Selector we now provide a solution that fully supports the deployment of their TLA technology,” said Othmar Pfannes, Ph.D., Founder and CEO of Genedata. “TLA, together with Genedata Selector, enables our customers to scale up their cell line development processes and generate results of the highest quality. This is another example of how Genedata—together with other technology leaders—supports our customers in the biopharma industry to increase the efficiency of R&D.”

About Genedata

Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.

http://www.genedata.com

LinkedIn | Twitter | YouTube

________________________________________

Contact

Miles Fisher-Pollard

Genedata

Public Relations

Phone: +41 61 511 85 61

pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Share article on social media or email:



SpaceAlarm Launches as The First Wearable Gadget That Makes It Easier to Be More Compliant with Social Distancing


COVID-19, coronavirus, social distancing, virus

SpaceAlarm is a small flashing light that affixes to clothing, a purse or backpack.

Social distancing has been proven to slow the spread of COVID-19 and help flatten the curve. Now there is a new wearable gadget that can help us all re-train our brain by reinforcing social distancing and awareness. SpaceAlarm is a small flashing light that affixes to clothing, a purse or backpack. Turn it on when leaving the house and it continually blinks making others more aware of your presence, thereby helping everyone maintain a six-foot distance.

Why is wearing SpaceAlarm important during the pandemic? The Centers for Disease Control and Prevention (CDC) states that limiting face-to-face contact with others is the best way to reduce the spread of COVID-19. This is best done through social distancing. In addition to not gathering in groups and staying out of crowded places and avoiding mass gatherings, it is very important to stay at least six feet from other people. SpaceAlarm helps everyone get used to the “new normal” of social distancing by continually blinking, allowing others to notice the wearer and keep their distance.

Wearing a SpaceAlarm is one more way to reduce the spread of COVID-19. It is important to stay away from others whenever possible because people can spread the virus before they even know they are sick. COVID-19 spreads mainly among people who are in close contact or within six feet of each other. In addition to wearing a face mask, SpaceAlarm is helpful in reducing the spread of coronavirus by allowing better compliance with social distancing by creating spatial awareness.

In addition, to help support those on the frontlines every day, one dollar from the sale of each SpaceAlarm will be donated to the American Nurses Foundation, the philanthropic arm of the American Nurses Association whose mission is to ‘transform the nation’s health through the power of nursing’.

SpaceAlarm comes in a 2-pack (two lights) for $9.98. It can only be purchased online at https://spacealarm.com and through online marketplaces. When you purchase SpaceAlarm you’re helping to keep yourself and loved ones safer while supporting nurses on the frontlines.

Media Contact

Ria Romano, Partner

RPR Public Relations, Inc.

Tel. 786-290-6413

Share article on social media or email:

Innovative Health Launches Virtual Learning Seminars in Wake of 2020 Heart Rhythm Scientific Sessions Cancellation


The chosen topics, all focused on how hospitals can reduce EP lab costs through better utilization of device reprocessing, will be particularly relevant as administrators and clinicians prepare for the reopening of EP labs…

Innovative Health, Inc. today announced the availability of three new informational web sessions, being held in early May, to help fill the learning gap left by the cancellation of this year’s Heart Rhythm Scientific Sessions. These sessions will educate administrators and clinicians on new and emerging opportunities for cost reductions through the reprocessing of advanced EP devices.

“When the ongoing novel coronavirus pandemic prompted the cancellation of the 2020 Heart Rhythm Scientific Sessions, administrators and clinicians lost access to their usual forum for learning about new technological and clinical advancements in our industry,” said Innovative Health CEO Rick Ferreira. “Innovative Health is helping to overcome this shared obstacle by bringing new educational programs to a virtual environment. The chosen topics, all focused on how hospitals can reduce EP lab costs through better utilization of device reprocessing, will be particularly relevant as administrators and clinicians prepare for the reopening of EP labs—and subsequent pent-up demand for procedures—when this ongoing health crisis recedes.”

The three webinars are as follows:

  • May 4 – How Specialty Reprocessing Helps You Save More: An overview of the current reprocessing landscape and how specialty reprocessors are improving cost-efficiencies in EP labs through their specific regulatory, scientific and program management competencies.
  • May 7 – Advanced Reprocessing Technology: Reprocessing of Lumened EP Devices: A technical look at new techniques for reprocessing some of the most complex devices used in today’s atrial fibrillation procedures, and an analysis of the cost savings opened up by recent FDA clearances in this space.
  • May 12 – Unaddressed Reprocessing Opportunities in the EP Lab: A future-looking evaluation of currently non-reprocessable EP devices that, if cleared for reprocessing, could open vast new opportunities for costs savings and greater access to EP procedures.


Administrators and clinicians can learn more and join these webinars by visiting Innovative Health’s virtual learning seminars here.

In addition to these new educational programs, Innovative Health also announced that 30 EP labs around the country have been awarded Innovative Health’s 2019 reprocessing award for financial and environmental sustainability achievements in the EP lab. The awards were presented to the labs in January and February of 2020. The awards celebrate hospitals that have reached high levels of success saving important financial resources in the EP lab by using reprocessed single-use devices. Several EP labs had reached savings of more than $1 million per year.

Innovative Health has an aggressive, committed FDA clearance program that allows the company to constantly add new devices to the EP lab’s reprocessing program, increasing savings over time. The company received FDA clearance to reprocess the Medtronic Achieve® Catheter Connecting Cable in January, completing its portfolio of Medtronic diagnostic EP and mapping catheters, as well as accessories. Another 3 devices are under review with FDA, and the company expects to make an additional 5-6 devices available for reprocessing, further distancing Innovative Health from its competitors that cannot offer these important savings opportunities to EP labs.

About Innovative Health

Innovative Health is an advanced medical device reprocessing company that offers smarter utilization of medical devices in hospitals’ cardiology and electrophysiology programs.

Share article on social media or email:

U.S. Fertility Rates Fall, Population Numbers Grow Larger and CO2 Levels Continue to Rise


NPG

While we should rejoice declining birthrates as beneficial to the long-term sustainability of our nation, we must recognize that immigration plays a pivotal role in our ability to truly turn the tide on climate change.

Negative Population Growth, Inc. has released the newest addition to their NPG Forum paper series. U.S. fertility rates are currently below replacement level but climate change continues to be a challenge. This paper, written by Edwin S. Rubenstein, titled Human Fertility and Climate Change studies the relationship between today’s plunging birthrates and global warming. Rubenstein states: “…U.S. population is projected to increase steadily through 2050… The reason? Immigration.” While we should rejoice declining birthrates as beneficial to the long-term sustainability of our nation, we must recognize that immigration plays a pivotal role in our ability to truly turn the tide on climate change.

“Fertility rates tend to fall during hard economic times, as people postpone having babies, and then rise as the economy recovers.” Rubenstein notes, while discussing that U.S. fertility rates are below the 2.1 replacement rate and have been for over 25 years. Adding to the scenario, Rubenstein considers the noteworthy increase of global temperatures, saying: “Since the 1960s each decade has been warmer than the previous one, by significant amounts. This trend is driven mainly by emissions of CO₂ and other heat-trapping emissions from the burning of fossil fuels.”

Leaning into the dangers of air pollution, Rubenstein brings the vulnerability of children into the conversation, stating: “Infants who survive the trauma of birth face a lifetime of health issues related to climate change.” He also observes that air pollution, in general, “killed 7 million people worldwide in 2016…more than half of these deaths are estimated to be from household air pollution, mainly from coal, wood, charcoal, and biomass, used for cooking.” Gathering the facts together, Rubenstein takes a look at a small movement of young adults choosing not to bear children — ultimately surmising: “A zero-child pledge is a luxury that most people on this Earth simply cannot afford…(and) even a universal one-child policy, imposed immediately in all countries would not prevent global population from rising significantly by 2100.”

He goes on to use China’s one child policy as an example of how government controlled family planning can go awry, explaining: “While many countries — including our own — are struggling with low fertility rates and aging populations, these issues are more pressing in China, because the country’s underdeveloped social safety net means that most older adults rely heavily on their families to pay for healthcare, retirement and other expenses…Making matters worse, China’s main state pension fund, which relies on tax revenues from its work force, could run out of money by 2035.” Rubenstein highlights that for China and the U.S., fertility rates have been below replacement level for decades and that the biggest difference — when it comes to population growth — is immigration, saying: “China is a country of mass emigration. Historically, we (U.S.) have been a country of mass immigration.”

Looking towards the future, Rubenstein echoes NPG’s belief that policies on migration and human fertility would bring our population down to a more viable level, saying: “a world population of 1.5 to 2 billion is needed for long-term sustainability.” Adding the earth’s rising temperatures into the equation, Rubenstein concludes that for the U.S. to get ahead of continued immigration-based population growth and climate change we must make a concerted effort to, over the course of many years, reduce our population numbers, writing: “A sustained period of negative net immigration would enable U.S. population to eventually shrink. As the world’s largest per capita CO₂ emitter, this would be a milestone in the war against global warming.”

Founded in 1972, NPG is a national nonprofit membership organization dedicated to educating the American public and political leaders regarding the damaging effects of population growth. We believe that our nation is already vastly overpopulated in terms of the long-range carrying capacity of its resources and environment. NPG advocates the adoption of its Proposed National Population Policy, with the goal of eventually stabilizing U.S. population at a sustainable level – far lower than today’s. We do not simply identify the problems – we propose solutions. For more information, visit our website at http://www.NPG.org, follow us on Facebook @NegativePopulationGrowth or follow us on Twitter @npg_org.

Share article on social media or email:



New Best selling book The Law of Creation is Opening Hearts & Minds, Showing the Way to Real Joy & Success


This is the first time that the 18 Universal laws behind The Law of Creation have been defined in practical terms, and not just theory

Every person has the innate ability to create their lives and feel joy and yet most are generally ‘cut off’ or disconnected from their personal power. One new book details the Science behind how people everywhere can reconnect to their creative powers.

The Law of Creation is a unique, comprehensive book that demonstrates the Physics and Science behind the power of Manifestation. Based on 18 Universal Laws, The Law of Creation clearly and methodically explains how moving from negative thoughts to affirmative living, removes any limits and ‘reboots the mind’ for greater success, joy and happiness.

“The good news, or for some people the bad news, is that you have created and are responsible for the life you are currently living,” says Steve Webster, co-author, husband, father and a successful, life-long entrepreneur. “The fact is you might not be happy with your life and you may wish for things to be different. The key to fixing this is firstly understanding how you created what you have (so far), and secondly understanding why you are unable to manifest what you consciously desire.”

According to Steve, some of his explanations involve physics and scientific principles such as quantum theory and wave function. He believes this is the first time that the 18 laws behind The Law of Creation have been defined in practical terms, and not just theory. He understands that some people do not need to know how it works; they just need to know that it does. However, the book thoughtfully explains the scientific process for analytical readers who may be skeptical about the creative process.

Throughout The Law of Creation there is a recurring theme of “what you think is what you become.” An optimist will look on the bright side of a bad event, will have expectations of happiness and good fortune and will generally exude hope. Optimism is more than just believing in a positive outcome. It encompasses stopping criticizing self and others, stopping judgment of self and others, and acceptance and forgiveness. Bad things will periodically happen to you—they are there for a reason. The reason is for you to learn a lesson, to improve your consciousness level. You might not be able to control events in your life, but you can control your responses to the events.

The Law of Creation co-authors Steve and Tracy Webster were childhood sweethearts whom have been married since 1993. Both experienced financial lack growing up, which led them to seek Spiritual and Scientific knowledge. Tracy studied Naturopathic Medicine and became a Bioenergetic Therapist. Steve focused on business, starting up three successful companies, which collectively earned over $100 million per year and employed 250 people. He then immersed himself in higher consciousness, metaphysics, and Science with an emphasis on the subconscious mind as a Licensed Hypnotherapist.

The Websters hard work paid off by 2006, when they were living in a beautiful 18,500 square foot home in an upmarket suburb, with several luxury cars, three holiday homes, and a 3000-acre game farm (safari). Then in January 2020, after four years filled with family deaths, business challenges, and major health & relationship issues, they called an emergency family meeting. It was here that Steve shared life-changing notes from his 2017 unpublished manuscript The Law of Creation with Tracy and their two adult daughters. After reading the entire book, Tracy felt immediately relieved of months of depression and was inspired to help Steve prepare the book for publication by late April 2020.

“Within two days, I was vibrating so much higher than I had been and felt joy again. I wanted to share The Law of Creation with everyone,” adds Tracy, a life-long seeker of wisdom, world traveler, and fellow Harley Davidson rider with husband Steve. “Everything in the book rang true to me, and while it was interesting and profound, I felt as if I already knew it. I think because it (this creative energy) is inherent in all of us. And when you are vibrating with love and gratitude, it is impossible to feel anything other than good.”

The Law of Creation also explains why concepts in books like The Secret work, and more importantly why they do not work. In essence, there are 18 Universal Laws yet The Secret and many other Law of Attraction programs only cover one or two of them. It is not vital that people know how each and every one of these 18 Laws works; but it helps their Creation ability to understand how the Laws affect their life, and the outcome of what they have Created.

Readers everywhere can now discover the trusted science and simple formula to manifest everything they want into their lives! Steve and Tracy share these principles of The Law of Creation with the world in their new bestselling book now available for sale in select bookstores and via Amazon. For more information about Steve and Tracy Webster and The Law of Creation visit: http://www.The-LawOfCreation.com.

# # #

The Law of Creation is 126 pages in paperback, 147 pages in Kindle version            

ISBN: 978-0-578-66101-8     Retail price: $9.99 paperback, $ 7.99 Kindle version.

Publisher: Expert Insights Publishing

About Steve & Tracy Webster

The Law of Creation co-authors Steve and Tracy Webster both came from humble beginnings. While at University, Steve had no money so he left his studies to get an entry level computer job. Fast forward twenty years, he earned his MBA, was Founder and CEO of three massively successful companies, and is a multiple #1 International Best-Selling Author. Steve also fully immersed himself in higher consciousness, metaphysics, and science with a focus on the subconscious mind as a licensed Hypnotherapist which led to the discovery that the principles he used to create his success are the same 18 Universal laws now discussed in The Law of Creation.

When Tracy was nine years old, her family was evicted from their home which culminated in her family moving homes like “gypsies”. This resulted in her attending eight different schools before the age of 12. Later in life, Tracy studied Quantum Bioenergetic Therapy where she discovered and used the powerful techniques you can now find in The Law of Creation to attract her amazing husband, Steve, her two lovely daughters, wealth and an idealistic lifestyle. Overcoming her childhood through the tools found in The Law of Creation taught her that there is no limit to what she can achieve.

Share article on social media or email:

The Solution to Mask Irritation


News Image

Body Glide Face Glide

The new Face Glide balm was immediately put to use on approval of hospital Chiefs of Nursing and Heads of Infection Control. One city hospital ordered 2,000 to get our new product to the entire staff.

Body Glide, the leading provider of topical protection against chafed skin, has launched Face Glide, an invisible barrier against rubbing by masks that causes irritation, chafing and raw skin. The company immediately pivoted to meet an overwhelming need and demand for protection coming from frontline healthcare and other essential workers. Concept to delivery into hospitals was accomplished in ten days, and now Body Glide is able to provide essential protection to everyone wearing masks.

“The new Face Glide balm was immediately put to use on approval of hospital Chiefs of Nursing and Heads of Infection Control,” said Bill Sternoff, Body Glide’s CEO. “One city hospital ordered 2,000 to get our new product to the entire staff.”

As seen in pictures of nurses and doctors, masks trap heat and moisture, and combined with pressure from fabric and straps needed to make masks effective, faces are rubbed. It stings the skin, it burns, causes red rash in mild cases, and in others it can lead to swelling, bleeding, and the possibility of infection.

Face Glide is a unique, non-messy, fragrance free balm that swipes on from a pocket-size tube to cheeks, ears, nose, chin, wherever masks rub faces. It’s easy to use, gentle on skin, but it’s effective hour after hour whether the masks are homemade, surgical, KN95s or N95 respirators, and it’s also effective with face shields. It’s sweat and water resistant but it lets skin breathe.

Because it’s not a lotion or other liquid, Face Glide balm will not run into the eyes. It will not harm rubber or latex, and it’s safe on children.

Face Glide balm is available for $4.99. For more information on the Body Glide new face product, please visit http://www.BodyGlide.com.

About Body Glide

Body Glide’s technically advanced skin protection formulas are as revolutionary today as in 1996 when it was instantly embraced at the Los Angeles Marathon. Availability in Canada followed in 1997, Europe in 1998, and today these products have found their way into the lives of people on every continent. They are gentle on the skin but work under extreme conditions — under water and even in the harsh conditions of Antarctica. Body Glide brand products are famous because they are clean, non-greasy, non-messy and have proven reliable for more than two decades.

EDITOR’S NOTE: To get more information about Body Glide, please contact Nancy Trent or Pam Wadler at 212-966-0024 or pam@trentandcompany.com.

Share article on social media or email:

Complimentary Webinar to Showcase Emerging Field of Cone Beam CT Imaging


“Cone Beam CT imaging techniques significantly reduce the complexity by removing the need for ‘slip ring’ technology that is essential for traditional CT systems.” observes Dr. Yorkston.

RadSite™, a CMS-recognized accrediting agency promoting quality-based advanced diagnostic imaging, is offering a complimentary webinar called An Overview of Cone Beam CT Imaging. The session will take place on May 6, 2020, at 2:00 p.m. ET and will last approximately one hour. Click here to register.

Leading experts in quality imaging will discuss the latest in Cone Beam CT Imaging in the United States in the May 6th webinar. Thousands of systems are now being used for diagnostic and interventional imaging. The session will highlight the opportunities and challenges associated with Cone Beam CT systems, including the need for national quality and performance standards.

The session will be moderated by Eliot Siegel, M.D., RadSite Chair, Standards Committee, and will feature the following speakers:

-David Luick, Vice President, Tungsten Medical Network

-Jenna Roller, PA-C, Clinical Applications Specialist, CurveBeam

-John Yorkston, Ph.D., Senior Research Scientist, Carestream Health Inc.

“It is interesting to compare the technology between a traditional CT system, where the patient must be moved through the fan beam of x-rays as it rotates around the patient multiple times, to a Cone Beam CT system, which uses a large-area detector to image an extended volume of the patient in a single rotation,” observes Dr. Yorkston. “Cone Beam CT imaging techniques significantly reduce the complexity by removing the need for ‘slip ring’ technology that is essential for traditional CT systems.”

“Cone Beam CT imaging has become a centerpiece for otolaryngology specialty care,” notes David Luick. “By allowing medical professionals to conveniently image fields of study covering the ears, nose, and throat, the provider can conveniently access a high resolution image at a lower dose that conventional CT exams. Cone Beam CT images can be used for both diagnosis and in the aid of treatment. A good example is image-guided sinus surgery.”

“Cone Beam CT systems are designed to capture three-dimensional weight-bearing and non-weight-bearing volumetric images of the body extremities,” adds Jenna Roller. “I will share with the webinar attendees some of the opportunities associated with Cone Beam CT systems, such as how it can support orthopedic practices and other specialty areas, along with some of the latest advancements.”

All three speakers serve on RadSite’s Cone Beam CT Standards Committee, which has been meeting for two years. RadSite anticipates the release of its new Cone Beam CT MIPPA Accreditation Program this summer, which features specialty standards for both dental and medical imaging providers.

RadSite is hosting two webinars related to Cone Beam CT imaging, each lasting one hour:

-An Overview of Cone Beam CT Imaging is scheduled on May 6, 2020, at 2:00 p.m. ET. Click here to register.

-2020 RadSite Cone Beam CT Standards Overview is scheduled on June 17, 2020, at 2:00 p.m. ET. Click here to register.

To listen to RadSite’s last webinar, “2020 RadSite Standards and Accreditation Updates,” which took place on April 15, 2020, or to listen to other webinars that have been previously recorded, go to https://radsitequality.com/webinars/.

RadSite offers a comprehensive, affordable, quality-based accreditation program that evaluates providers on established industry standards and best practices. Working with health plans and their participating providers helps raise imaging standards through meaningful imaging quality and patient safety protocols. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services and more than 350 payers and radiology benefit managers.

                                                                 ###

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite’s programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email:

Murrieta Genomics and SimplSeq to Participate in Life Science Nation’s Digital RESI Partnering Event April 29 and 30


We are now ready to share this with investors, and this is the perfect platform to launch our fundraising.

Murrieta Genomics, the launch pad for genomic sequencing startups, and SimplSeq, a wholly owned subsidiary company focused on innovative sample preparation for genomic sequencing, will be participating in a virtual partnering event being held April 29 and 30. The event is hosted by Life Science Nation, an organization founded to help move science forward and be part of the change that is coming to the life science domain.

“Murrieta Genomics wants to launch the next great genomic sequencing companies,” stated Jay Goth, CEO of Murrieta Genomics. “We believe that we are in the very early phase of precision medicine and genomic sequencing is one of the fundamental technologies driving this new trend. Life Science Nation provides an incredibly important service to early stage life science companies by connecting them with products, services and capital.”

The digital partnering event is an innovative approach to connecting companies that was developed in response to the current Coronavirus pandemic. Life Science Nation had to shift their European conference held in March to a digital platform due to the restrictions on travel and found that opening the conference to a virtual audience was a game changer.

“Digital RESI Global doubled our predicted attendee turnout with investment partners and fundraising CEOs. The metrics are actually quite interesting and surprised us in revealing the pent-up demand for action in the life science arena in these troubled times,” stated Dennis Ford, founder and CEO of Life Science Nation. “Partnering led the way and Panels, Workshops and Company Presentations did remarkably well. I never would have thought that these troubled times would have contributed to a new model that seems to be shifting the paradigm.”

During the March RESI conference, over 1,200 meetings were booked over three major continents, with 546 attendees successfully scheduling meetings. This bodes well for the upcoming partnering conference, according to Goth. “I attended the RESI conference in January in San Francisco and was impressed by the number of meetings I had with investors and the quality of those meetings,” he said. “You can reach out to qualified investors and request a meeting and if they agree, then there is a pre-existing interest in what you have to say.”

“SimplSeq is a new internally developed incubator company,” said John Powers, COO of Murrieta Genomics and CEO of SimplSeq. “Brandon Young, our CTO and Lab Director, has been at the bench for over 20 years and he has encountered frustrations with traditional sample preparation methods and decided to come up with some new ideas. As he developed these concepts, we realized that he was transforming a critical part of the genomic sequencing process and we decided to patent and commercialize them. We are now ready to share this with investors, and this is the perfect platform to launch our fundraising.”

Murrieta Genomics is also on the lookout for new potential candidates for the incubator. “We can offer genomic startups critical resources that most life science incubators and accelerators don’t,” said Goth. “For example, our advisory board is comprised of industry leaders – not only in the genomic and science areas, but also in necessary fields including legal, accounting, human resources and investment banking.”

“We don’t think that genomic startups should be spending money building a lab, hiring technicians, and burning up capital to generate the data they need to prove out their concept. We offer them the sequencing know-how and access to resources that would normally be cost prohibitive with no bench fees or overhead costs except for hard costs such as reagents. People with genomic domain knowledge can prove their science while building a business model before reaching out to investors.”

Both companies will also be participating in the next digital RESI conference slated for early June. At this event there will be one on one partnering, investor panels, workshops for life science entrepreneurs, virtual pitch sessions, innovation challenges and more. It is scheduled for three days, June 8, 9 and 10. You can register for Digital RESI 3-Day Conference June 8-10 here and use the promo code “RESIMG100” to save $100 off your registration.

LSN invites all global early-stage companies across Biotech, Medtech, Diagnostics & Digital Health to apply for the Digital RESI June 8-10 Innovation Challenge. The top 30 scoring companies will virtually showcase their technology on their own dedicated page featured on the Digital RESI “Live Agenda,” gaining more exposure in LSN’s Global Fundraising Ecosystem of investors and strategic partners. You can apply for the Innovation Challenge here. The application deadline is May 11th.

About Murrieta Genomics

Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The founders of Murrieta Genomics have extensive background in business, finance, science and technology. They are supplemented with a prestigious advisory board from both business and science. The company provides Next Generation Sequencing (NGS) services, hands-on consulting, review, appraisal and guidance. In addition, it provides help with company value propositions and potential seed funding support to qualified incubator graduates. For more information visit http://www.murrietagenomics.com.

Murrieta Genomics is part of the Murrieta Innovation Center, a building owned by the city of Murrieta and dedicated to supporting life science companies. The Innovation Center has medical device, therapeutic, software, clinical research and of course genomic companies that are working hard to advance new ideas and innovations that can impact the world in a positive way. The Center is also a resource for all types of local startup companies, offering services and workshops from a local SBDC, several veteran organizations, a SCORE branch and more.

About Life Science Nation’s RESI Conference

The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What is unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics, and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.

Specialty telehealth vendor Anytime Pediatrics achieves record growth in Q1


News Image

We are humbled and proud to be a company ready to respond in this time of need.

Anytime Pediatrics, the first and only pediatric-specific telemedicine solution, announced explosive growth today, making it one of the fastest growing healthcare technology companies and a true innovator in virtual care. Anytime Pediatrics is helping patients stay connected with pediatricians they know and trust during the COVID-19 pandemic.

“I have always believed in the power of relationships, especially between physicians, clinicians and their patients,” said Mick Connors, MD and CEO of Anytime Pediatrics. “Our rapid growth is a testament to the fact that relationships still matter, especially for the unique bond between a family and their child’s pediatrician. This crisis has ‘pushed’ pediatricians and patients to virtual care, not due to the love of technology, but because we look for unique ways to foster the relationships we truly need in our lives. We are humbled and proud to be a company ready to respond in this time of need.”

The company’s early 2020 success validates that “pediatric-specific” really matters, and pediatricians value a complete telemedicine product, community and innovation. Anytime Pediatrics believes in keeping care local, and is committed to delivering technology that strengthens relationships and supports healthy lives.

“I’m glad that this horrible crisis has forced me to embrace a new way of practicing medicine, and I’m grateful that I found a partner in this endeavor that was as quick, helpful, easy to work with and responsive as you guys,” said Dr. John Dallenbach, owner of East Elm Pediatrics. “We all love Anytime Pediatrics.”

About Anytime Pediatrics

Anytime Pediatrics is an industry leading telemedicine solution, built exclusively for pediatricians and their patients. The innovative technology company is advancing how quality care can be delivered within the medical home and is committed to making healthcare more convenient, accessible and affordable. The fast growing start up, Anytime Telehealth Inc, was founded in 2016 and is currently headquartered in Nashville, TN.

Share article on social media or email: